Eligibility depends on a clinical review of your BMI, health history, and needs
Figure 4: Opportunities Outside of Diabetes and Obesity for Incretin Mimetics As mentioned earlier, NASH is an area that has attracted a high level of manufacturer attention, as the liver disease is associated with metabolic syndrome and represents an area of large commercial opportunity with significant unmet medical need
Gastroparesis (stomach paralysis)
GLP-1 drugs primarily attract users aged 25 to 34, and 35 to 44, noted Sibley, explaining that women dominate the younger age group, while men make up the majority in the older bracket
HUA is an abnormally elevated blood UA concentration caused by a variety of triggers and can be diagnosed as blood UA 7 mg/dL in men and serum uric acid 6 mg/dL in women (Valsaraj et al., 2020
10.1001/archinte.161.3.397